The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 24, 2018
Filed:
Jun. 09, 2014
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Mark W. Embrey, Harleysville, PA (US);
Kerim Babaoglu, Lansdale, PA (US);
Abbas Walji, Lansdale, PA (US);
John S. Wai, Harleysville, PA (US);
Paul J. Coleman, Harleysville, PA (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 487/14 (2006.01); C07D 498/14 (2006.01); C07D 491/048 (2006.01); A61K 31/5383 (2006.01); A61K 31/4965 (2006.01); A61K 45/06 (2006.01); A61K 31/4985 (2006.01);
U.S. Cl.
CPC ...
C07D 487/14 (2013.01); A61K 31/4985 (2013.01); A61K 31/5383 (2013.01); A61K 45/06 (2013.01); C07D 491/048 (2013.01); C07D 498/14 (2013.01);
Abstract
The present invention relates to Fused Tricyclic Heterocycle Derivatives of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, X, Y, m, R1, R5, Ra and Rb are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Heterocycle Derivative, and methods of using the Fused Tricyclic Heterocycle Derivatives for treating or preventing HIV infection in a subject.